Inhalational vs. Intravenous anesthesia: is opposition helpful for clinicians?

An intense debate focusing on the polluting effect of volatile anesthetics has recently called into question their role and importance, even though they have been fundamental to general anesthesia until now. In this brief narrative review, we analyze the advantages and limitations of inhalation anesthesia in comparison with intravenous anesthesia in both adult and pediatric populations. The aim of the review is to assist anesthesiologists in making an informed and objective choice between the 2 techniques, considering that a single aspect—environmental pollution—although important, cannot be the only parameter on which to base the decision of how to perform general anesthesia.

Inhalational anesthetics; Sevoflurane; Desflurane; Propofol; Total intravenous anesthesia; Pharmacokinetics of inhalational anesthetics; General anesthesia

[1] Hammer S, Eichlseder M, Klivinyi C, Lang-Illievich K, Moser A, Pichler A, et al. Effects of departmental green anaesthesia interventions on carbon dioxide equivalent emissions: a systematic review. British Journal of Anaesthesia. 2025; 135: 79–88.

[2] Kranke P, Jakobsson J, Marin L, Kleinberg RL, Landoni G, Reinoso-Barbero F, et al. Protecting clinician autonomy and patient safety within the climate debate: the case for desflurane in modern anaesthesia. Current Opinion in Anaesthesiology. 2026; 39: 115–125.

[3] Marin L, Kleinberg RL. Climate change, emissions of volatile anesthetics, and policy making: the case of desflurane. Anesthesia & Analgesia. 2025; 141: 123–127.

[4] Schraag S, Pradelli L, Alsaleh AJO, Bellone M, Ghetti G, Chung TL, et al. Propofol vs. inhalational agents to maintain general anaesthesia in ambulatory and in-patient surgery: a systematic review and meta-analysis. BMC Anesthesiology. 2018; 18: 162.

[5] Kissin I. Components of general anesthesia: history of the concept transformation. Anesthesia & Analgesia. 2023; 137: 702–707.

[6] Eger E II, Saidman LJ, Brandstater B. Minimum alveolar anesthetic concentration: a standard of anesthetic potency. Anesthesiology. 1965; 26: 756–763.

[7] Aranake A, Mashour GA, Avidan MS. Minimum alveolar concentration: ongoing relevance and clinical utility. Anaesthesia. 2013; 68: 512–522.

[8] Dilger JP. From individual to population: the minimum alveolar concentration curve. Current Opinion in Anaesthesiology. 2006; 19: 390–396.

[9] Stoelting RK, Longnecker DE, Eger EI II. Minimum alveolar concentrations in man on awakening from methoxyflurane, halothane, ether and fluroxene anesthesia: MAC awake. Anesthesiology. 1970; 33: 5–9.

[10] Hendrickx JFA, De Wolf AM. End-tidal anesthetic concentration: monitoring, interpretation, and clinical application. Anesthesiology. 2022; 136: 985–996.

[11] Eger EI II. Age, minimum alveolar anesthetic concentration, and minimum alveolar anesthetic concentration-awake. Anesthesia & Analgesia. 2001; 93: 947–953.

[12] Sahinovic MM, Struys MMRF, Absalom AR. Clinical pharmacokinetics and pharmacodynamics of propofol. Clinical Pharmacokinetics. 2018; 57: 1539–1558.

[13] Pandit JJ, Andrade J, Bogod DG, Hitchman JM, Jonker WR, Lucas N, et al.; Royal College of Anaesthetists and the Association of Anaesthetists of Great Britain and Ireland. The 5th National Audit Project (NAP5) on accidental awareness during general anaesthesia: summary of main findings and risk factors. Anaesthesia. 2014; 69: 1089–1101.

[14] Fang F, Sun J, Wu Q, Feng L, Fan Y, Ye J, et al. Protective effect of sevoflurane on vascular endothelial glycocalyx in patients undergoing heart valve surgery: a randomised controlled trial. European Journal of Anaesthesiology. 2021; 38: 477–486.

[15] Adembri C, Venturi L, Tani A, Chiarugi A, Gramigni E, Cozzi A, et al. Neuroprotective effects of propofol in models of cerebral ischemia: inhibition of mitochondrial swelling as a possible mechanism. Anesthesiology. 2006; 104: 80–89.

[16] Adembri C, Venturi L, Pellegrini-Giampietro DE. Neuroprotective effects of propofol in acute cerebral injury. CNS Drug Reviews. 2007; 13: 333–351.

[17] Kotani Y, Pruna A, Turi S, Borghi G, Lee TC, Zangrillo A, et al. Propofol and survival: an updated meta-analysis of randomized clinical trials. Critical Care. 2023; 27: 139.

[18] Kotani Y, Pruna A, Landoni G. Mechanisms of action of the detrimental effects of propofol on survival. Journal of Cardiothoracic and Vascular Anesthesia. 2023; 37: 2176–2180.

[19] Bernat M, Cuvillon P, Brieussel T, Roche M, Remacle A, Leone M, et al. The carbon footprint of general anaesthesia in adult patients: a multicentre observational comparison of intravenous and inhalation anaesthetic strategies in 35,242 procedures. British Journal of Anaesthesia. 2025; 134: 1620–1627.

[20] Ramly MS, Buggy DJ. Anesthetic techniques and cancer outcomes: what is the current evidence? Anesthesia & Analgesia. 2025; 140: 768–777.

[21] Rübsam M, Kruse P, Dietzler Y, Kropf M, Bette B, Zarbock A, et al. A call for immediate climate action in anesthesiology: routine use of minimal or metabolic fresh gas flow reduces our ecological footprint. Canadian Journal of Anesthesia. 2023; 70: 301–312.

[22] Deng X, Yu H, Wang W, Wu Q, Wei H, Deng J, et al. Effect of volatile versus propofol anaesthesia on major complications and mortality after cardiac surgery: a multicentre randomised trial. British Journal of Anaesthesia. 2024; 133: 296–304.

[23] Landoni G, Lomivorotov VV, Nigro Neto C, Monaco F, Pasyuga VV, Bradic N, et al. Volatile anesthetics versus total intravenous anesthesia for cardiac surgery. The New England Journal of Medicine. 2019; 380: 1214–1225.

[24] Uhlig C, Bluth T, Schwarz K, Deckert S, Heinrich L, De Hert S, et al. Effects of volatile anesthetics on mortality and postoperative pulmonary and other complications in patients undergoing surgery: a systematic review and meta-analysis. Anesthesiology. 2016; 124: 1230–1245.

[25] Zangrillo A, Lomivorotov VV, Pasyuga VV, Belletti A, Gazivoda G, Monaco F, et al.; MYRIAD Study Group. Effect of volatile anesthetics on myocardial infarction after coronary artery surgery: a post hoc analysis of a randomized trial. Journal of Cardiothoracic and Vascular Anesthesia. 2022; 36: 2454–2462.

[26] Kampman JM, Hermanides J, Hollmann MW, Gilhuis CN, Bloem WA, Schraag S, et al. Mortality and morbidity after total intravenous anaesthesia versus inhalational anaesthesia: a systematic review and meta-analysis. eClinicalMedicine. 2024; 72: 102636.

[27] Daccache N, Wu Y, Jeffries SD, Zako J, Harutyunyan R, Pelletier ED, et al. Safety and recovery profile of patients after inhalational anaesthesia versus target-controlled or manual total intravenous anaesthesia: a systematic review and meta-analysis of randomised controlled trials. British Journal of Anaesthesia. 2025; 134: 1474–1485.

[28] Chandler JR, Myers D, Mehta D, Whyte E, Groberman MK, Montgomery CJ, et al. Emergence delirium in children: a randomized trial to compare total intravenous anesthesia with propofol and remifentanil to inhalational sevoflurane anesthesia. Pediatric Anesthesia. 2013; 23: 309–315.

[29] Costi D, Cyna AM, Ahmed S, Stephens K, Strickland P, Ellwood J, et al. Effects of sevoflurane versus other general anaesthesia on emergence agitation in children. Cochrane Database of Systematic Reviews. 2014; 2014: CD007084.

[30] Davidson AJ, Disma N, de Graaff JC, Withington DE, Dorris L, Bell G, et al. Neurodevelopmental outcome at 2 years of age after general anaesthesia and awake-regional anaesthesia in infancy (GAS): an international multicentre, randomised controlled trial. The Lancet. 2016; 387: 239–250.

[31] Meretoja OA. Neuromuscular block and current treatment strategies for its reversal in children. Pediatric Anesthesia. 2010; 20: 591–604.

[32] Fuchs-Buder T, Romero CS, Lewald H, Lamperti M, Afshari A, Hristovska A, et al. Peri-operative management of neuromuscular blockade: a guideline from the European society of anaesthesiology and intensive care. European Journal of Anaesthesiology. 2023; 40: 82–94.

[33] Gupta N, Gupta A, Narayanan M R V. Current status of nitrous oxide use in pediatric patients. World Journal of Clinical Pediatrics. 2022; 11: 93–104.

[34] Zhao Y, Qin F, Liu Y, Dai Y, Cen X. The safety of propofol versus sevoflurane for general anesthesia in children: a meta-analysis of randomized controlled trials. Frontiers in Surgery. 2022; 9: 924647.

[35] Rigby-Jones AE, Sneyd JR. Propofol and children—what we know and what we do not know. Pediatric Anesthesia. 2011; 21: 247–254.

[36] Morton NS. Total intravenous anaesthesia (TIVA) in paediatrics: advantages and disadvantages. Pediatric Anesthesia. 1998; 8: 189–194.

[37] Kojima T, Nakahari H, Ikeda M, Kurimoto M. Impact of low-dose sevoflurane with propofol-based anesthesia on motor-evoked potentials in infants: a single-arm crossover pilot study. Journal of Anesthesia. 2025; 39: 93–100.

[38] Bray RJ. Propofol infusion syndrome in children. Pediatric Anesthesia. 1998; 8: 491–499.